EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

YTHDF3 Enhances Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoporosis by Promoting TBX19 Expression

Qianke Tao, Qiaonan Ye iD, Chengpeng Yang, Yuping Xie, Xuemei Long iD, Long Bai, Zhiyuan Zhang, Qianwei Li, Dan Tan iD, Jingang Xiao iD

Cell Proliferation · 2026-11 · 59 (11)

DOI: 10.1111/cpr.70240 ↗

At a glance

Journal article in Cell Proliferation, published online on 2026-06-03. Written by Qianke Tao and 9 co-authors. Institution: Department of Plastic and Burn Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China. Major MEDLINE topics: Mesenchymal Stem Cells, Osteoporosis, Osteogenesis, Cell Differentiation. Cited 1 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Science and Technology Department of Sichuan Province, Open Project of State Key Laboratory of Oral Diseases.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

N 6 ‐methyladenosine (m 6 A) modification is critically involved in regulating the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), yet the functional contributions of m 6 A reader proteins in osteoporosis remain poorly defined. In this study, we found that osteoporosis in rats correlates with severe bone loss and diminished osteogenic potential of BMSCs, accompanied by down‐regulation of the m 6 A reader YTHDF3. Functional assays showed that YTHDF3 promotes osteogenic differentiation of BMSCs. RNA‐sequencing analysis identified the transcription factor TBX19 as a key downstream mediator of YTHDF3. Subsequent investigations confirmed that Tbx19 knockdown not only attenuated the osteogenic capacity of BMSCs but also abrogated the pro‐osteogenic effect of Ythdf3 overexpression. Moreover, in vivo experiments demonstrated that Ythdf3 overexpression enhances the bone‐forming ability of osteoporotic BMSCs. Collectively, our results reveal that YTHDF3 acts as a positive regulator of BMSC osteogenesis, largely through regulating TBX19, and that its down‐regulation contributes to osteoporotic pathogenesis. These findings propose YTHDF3 as a novel potential therapeutic target for the treatment of osteoporosis.

Subjects

MeSH terms (MEDLINE)

Mesenchymal Stem CellsOsteoporosisOsteogenesisCell DifferentiationRNA-Binding ProteinsT-Box Domain ProteinsAnimalsRatsRats, Sprague-DawleyBone Marrow CellsCells, CulturedMale

Substances

RNA-Binding ProteinsT-Box Domain Proteins

Authors and institutions

  • Department of Plastic and Burn Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Luzhou Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
  • Department of Oral and Maxillofacial Surgery, The Affiliated Hospital, Southwest Medical University, Luzhou, China.
  • Department of Stomatology, Leshan Municipal People's Hospital, Leshan, China.
  • Department of Oral Implantology, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.
  • Department of Periodontal and Mucosal Diseases, The Affiliated Stomatological Hospital, Southwest Medical University, Luzhou, China.

ORCID profiles: Qiaonan Ye, Xuemei Long, Dan Tan, Jingang Xiao

Funding

  • National Natural Science Foundation of China
  • Science and Technology Department of Sichuan Province
  • Open Project of State Key Laboratory of Oral Diseases
  • Science and Technology Project of Health Commission of Sichuan Province
  • Luzhou Municipal Science and Technology Program Project
  • Stomatological Project of Southwest Medical University
  • Research Start-up Fund for Doctoral Fellows of the Affiliated Stomatological Hospital of Southwest Medical University
  • Young Scientists Research Ascending Program of the Affiliated Stomatological Hospital of Southwest Medical University

Cite

APA

Tao, Q., Ye, Q., Yang, C., Xie, Y., Long, X., Bai, L., Zhang, Z., Li, Q., Tan, D., & Xiao, J. (2026). YTHDF3 Enhances Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoporosis by Promoting TBX19 Expression. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70240

Vancouver

Tao Q, Ye Q, Yang C, Xie Y, Long X, Bai L, et al. YTHDF3 Enhances Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoporosis by Promoting TBX19 Expression. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70240

BibTeX
@article{Tao2026,
  author = {Tao, Qianke and Ye, Qiaonan and Yang, Chengpeng and Xie, Yuping and Long, Xuemei and Bai, Long and Zhang, Zhiyuan and Li, Qianwei and Tan, Dan and Xiao, Jingang},
  title = {YTHDF3 Enhances Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoporosis by Promoting TBX19 Expression},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {11},
  doi = {10.1111/cpr.70240}
}
Start for free →